Enhanced Apoptosis in Hepatocellular Carcinoma via Nanoscale Liposomal Codelivery of Ginsenoside CK and Sorafenib
ACS Applied Nano Materials · 20.03.2026 · 9 (11) · 5230-5244
DOI: 10.1021/acsanm.6c00711 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 09.03.2026. Verfasst von Xuchao Zha und 10 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Young Talent Support Program of the Shaanxi Provincial Association for Science and Technology, Xianyang Innovation Service Capability Support Plan, Shaanxi University Youth Science and Technology Innovation Team.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Young Talent Support Program of the Shaanxi Provincial Association for Science and Technology
- Xianyang Innovation Service Capability Support Plan
- Shaanxi University Youth Science and Technology Innovation Team
- Xi’an Key Laboratory of Textile and Chemical Additives Performance Assessment Reward and Subsidy Project
Zitieren
APA
Zha, X., Yuan, L., Gao, N., Zhang, Y., Zhang, X., Wang, W., Ma, B., Liu, Y., Chen, Z., Wu, Z., & He, Y. (2026). Enhanced Apoptosis in Hepatocellular Carcinoma via Nanoscale Liposomal Codelivery of Ginsenoside CK and Sorafenib. ACS Applied Nano Materials, 9(11), 5230-5244. https://doi.org/10.1021/acsanm.6c00711
Vancouver
Zha X, Yuan L, Gao N, Zhang Y, Zhang X, Wang W, et al. Enhanced Apoptosis in Hepatocellular Carcinoma via Nanoscale Liposomal Codelivery of Ginsenoside CK and Sorafenib. ACS Applied Nano Materials. 2026;9(11):5230-5244. doi:10.1021/acsanm.6c00711
BibTeX
@article{Zha2026,
author = {Zha, Xuchao and Yuan, Lijuan and Gao, Naiyue and Zhang, Yueman and Zhang, Xinyue and Wang, Wenfei and Ma, Bo and Liu, Yuting and Chen, Zihan and Wu, Zhansheng and He, Yanhui},
title = {Enhanced Apoptosis in Hepatocellular Carcinoma via Nanoscale Liposomal Codelivery of Ginsenoside CK and Sorafenib},
journal = {ACS Applied Nano Materials},
year = {2026},
volume = {9},
number = {11},
pages = {5230--5244},
doi = {10.1021/acsanm.6c00711}
}
EUVIMED